世界の牛胎児血清(FCS)市場2022年:市場規模予測(~2028年)

■ 英語タイトル:Global Fetal Calf Serum (FCS) Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート(データ管理コード:GIR22NO19323)■ 発行会社/調査会社:GlobalInfoResearch
■ 商品コード:GIR22NO19323
■ 発行日:2022年11月(※2025年版があります。お問い合わせください。)
■ 調査対象地域:グローバル
■ 産業分野:医薬品
■ ページ数:118
■ レポート言語:英語
■ レポート形式:PDF
■ 納品方式:Eメール(注文後2-3日)
■ 販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥528,960見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,220 ⇒換算¥793,440見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,057,920見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能)
GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[世界の牛胎児血清(FCS)市場2022年:市場規模予測(~2028年)]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

牛胎児血清(FCS)市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の牛胎児血清(FCS)の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx%の成長率で成長すると予想されます。

牛胎児血清(FCS)市場は種類と用途によって区分されます。2017年~2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・北米産、南米産、オーストラリア産、その他

用途別セグメントは次のように区分されます。
・研究開発、商業生産

世界の牛胎児血清(FCS)市場の主要な市場プレーヤーは以下のとおりです。
・Thermo Fisher、GE Healthcare、Sigma-Aldrich、Merck、Moregate BioTech、Gemini、Atlanta Biologicals、Tissue Culture Biologicals、Bovogen、Biowest、Internegocios、RMBIO、Biological Industries、PAN-Biotech、VWR、Corning

地域別セグメントは次の地域・国をカバーします。
・北米(米国、カナダ、メキシコ)
・ヨーロッパ(ドイツ、フランス、イギリス、ロシア、イタリア)
・アジア太平洋(日本、中国、韓国、インド、東南アジア、オーストラリア)
・南アメリカ(ブラジル、アルゼンチン、コロンビア)
・中東およびアフリカ(サウジアラビア、UAE、エジプト、南アフリカ)

本調査レポートの内容は計15章あります。
・第1章では、牛胎児血清(FCS)製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な牛胎児血清(FCS)メーカーの企業概要、2019年~2022年までの牛胎児血清(FCS)の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な牛胎児血清(FCS)メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年~2028年までの地域別牛胎児血清(FCS)の販売量、売上、成長性を示しています。
・第5、6章では、2017年~2028年までの牛胎児血清(FCS)の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年~2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年~2028年までの主要地域での牛胎児血清(FCS)市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および牛胎児血清(FCS)の産業チェーンを掲載しています。
・第13、14、15章では、牛胎児血清(FCS)の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 牛胎児血清(FCS)の概要
- 種類別分析(2017年vs2021年vs2028年):北米産、南米産、オーストラリア産、その他
- 用途別分析(2017年vs2021年vs2028年):研究開発、商業生産
- 世界の牛胎児血清(FCS)市場規模・予測
- 世界の牛胎児血清(FCS)生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報(企業概要、製品概要、販売量、価格、売上)
- Thermo Fisher、GE Healthcare、Sigma-Aldrich、Merck、Moregate BioTech、Gemini、Atlanta Biologicals、Tissue Culture Biologicals、Bovogen、Biowest、Internegocios、RMBIO、Biological Industries、PAN-Biotech、VWR、Corning
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年:北米産、南米産、オーストラリア産、その他
・用途別分析2017年-2028年:研究開発、商業生産
・牛胎児血清(FCS)の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模:アメリカ、カナダ、メキシコなど
・牛胎児血清(FCS)のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模:ドイツ、イギリス、フランス、ロシア、イタリアなど
・牛胎児血清(FCS)のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模:中国、日本、韓国、インド、東南アジア、オーストラリアなど
・牛胎児血清(FCS)の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模:ブラジル、アルゼンチンなど
・牛胎児血清(FCS)の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模:サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Fetal Calf Serum (FCS) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Fetal Calf Serum (FCS) market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Research & Development accounting for % of the Fetal Calf Serum (FCS) global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While North America-sourced segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Fetal Calf Serum (FCS) include Thermo Fisher, GE Healthcare, Sigma-Aldrich, Merck, and Moregate BioTech, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Fetal Calf Serum (FCS) market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
North America-sourced
South America-sourced
Australia-sourced
Others
Market segment by Application can be divided into
Research & Development
Commercial Production
The key market players for global Fetal Calf Serum (FCS) market are listed below:
Thermo Fisher
GE Healthcare
Sigma-Aldrich
Merck
Moregate BioTech
Gemini
Atlanta Biologicals
Tissue Culture Biologicals
Bovogen
Biowest
Internegocios
RMBIO
Biological Industries
PAN-Biotech
VWR
Corning
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Fetal Calf Serum (FCS) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Fetal Calf Serum (FCS), with price, sales, revenue and global market share of Fetal Calf Serum (FCS) from 2019 to 2022.
Chapter 3, the Fetal Calf Serum (FCS) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Fetal Calf Serum (FCS) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Fetal Calf Serum (FCS) market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Fetal Calf Serum (FCS).
Chapter 13, 14, and 15, to describe Fetal Calf Serum (FCS) sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次(コンテンツ)***

1 Market Overview
1.1 Fetal Calf Serum (FCS) Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Fetal Calf Serum (FCS) Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 North America-sourced
1.2.3 South America-sourced
1.2.4 Australia-sourced
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Fetal Calf Serum (FCS) Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Research & Development
1.3.3 Commercial Production
1.4 Global Fetal Calf Serum (FCS) Market Size & Forecast
1.4.1 Global Fetal Calf Serum (FCS) Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Fetal Calf Serum (FCS) Sales in Volume (2017-2028)
1.4.3 Global Fetal Calf Serum (FCS) Price (2017-2028)
1.5 Global Fetal Calf Serum (FCS) Production Capacity Analysis
1.5.1 Global Fetal Calf Serum (FCS) Total Production Capacity (2017-2028)
1.5.2 Global Fetal Calf Serum (FCS) Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Fetal Calf Serum (FCS) Market Drivers
1.6.2 Fetal Calf Serum (FCS) Market Restraints
1.6.3 Fetal Calf Serum (FCS) Trends Analysis
2 Manufacturers Profiles
2.1 Thermo Fisher
2.1.1 Thermo Fisher Details
2.1.2 Thermo Fisher Major Business
2.1.3 Thermo Fisher Fetal Calf Serum (FCS) Product and Services
2.1.4 Thermo Fisher Fetal Calf Serum (FCS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 GE Healthcare
2.2.1 GE Healthcare Details
2.2.2 GE Healthcare Major Business
2.2.3 GE Healthcare Fetal Calf Serum (FCS) Product and Services
2.2.4 GE Healthcare Fetal Calf Serum (FCS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Sigma-Aldrich
2.3.1 Sigma-Aldrich Details
2.3.2 Sigma-Aldrich Major Business
2.3.3 Sigma-Aldrich Fetal Calf Serum (FCS) Product and Services
2.3.4 Sigma-Aldrich Fetal Calf Serum (FCS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Merck
2.4.1 Merck Details
2.4.2 Merck Major Business
2.4.3 Merck Fetal Calf Serum (FCS) Product and Services
2.4.4 Merck Fetal Calf Serum (FCS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Moregate BioTech
2.5.1 Moregate BioTech Details
2.5.2 Moregate BioTech Major Business
2.5.3 Moregate BioTech Fetal Calf Serum (FCS) Product and Services
2.5.4 Moregate BioTech Fetal Calf Serum (FCS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Gemini
2.6.1 Gemini Details
2.6.2 Gemini Major Business
2.6.3 Gemini Fetal Calf Serum (FCS) Product and Services
2.6.4 Gemini Fetal Calf Serum (FCS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Atlanta Biologicals
2.7.1 Atlanta Biologicals Details
2.7.2 Atlanta Biologicals Major Business
2.7.3 Atlanta Biologicals Fetal Calf Serum (FCS) Product and Services
2.7.4 Atlanta Biologicals Fetal Calf Serum (FCS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Tissue Culture Biologicals
2.8.1 Tissue Culture Biologicals Details
2.8.2 Tissue Culture Biologicals Major Business
2.8.3 Tissue Culture Biologicals Fetal Calf Serum (FCS) Product and Services
2.8.4 Tissue Culture Biologicals Fetal Calf Serum (FCS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Bovogen
2.9.1 Bovogen Details
2.9.2 Bovogen Major Business
2.9.3 Bovogen Fetal Calf Serum (FCS) Product and Services
2.9.4 Bovogen Fetal Calf Serum (FCS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Biowest
2.10.1 Biowest Details
2.10.2 Biowest Major Business
2.10.3 Biowest Fetal Calf Serum (FCS) Product and Services
2.10.4 Biowest Fetal Calf Serum (FCS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Internegocios
2.11.1 Internegocios Details
2.11.2 Internegocios Major Business
2.11.3 Internegocios Fetal Calf Serum (FCS) Product and Services
2.11.4 Internegocios Fetal Calf Serum (FCS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 RMBIO
2.12.1 RMBIO Details
2.12.2 RMBIO Major Business
2.12.3 RMBIO Fetal Calf Serum (FCS) Product and Services
2.12.4 RMBIO Fetal Calf Serum (FCS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Biological Industries
2.13.1 Biological Industries Details
2.13.2 Biological Industries Major Business
2.13.3 Biological Industries Fetal Calf Serum (FCS) Product and Services
2.13.4 Biological Industries Fetal Calf Serum (FCS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 PAN-Biotech
2.14.1 PAN-Biotech Details
2.14.2 PAN-Biotech Major Business
2.14.3 PAN-Biotech Fetal Calf Serum (FCS) Product and Services
2.14.4 PAN-Biotech Fetal Calf Serum (FCS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 VWR
2.15.1 VWR Details
2.15.2 VWR Major Business
2.15.3 VWR Fetal Calf Serum (FCS) Product and Services
2.15.4 VWR Fetal Calf Serum (FCS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 Corning
2.16.1 Corning Details
2.16.2 Corning Major Business
2.16.3 Corning Fetal Calf Serum (FCS) Product and Services
2.16.4 Corning Fetal Calf Serum (FCS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Fetal Calf Serum (FCS) Breakdown Data by Manufacturer
3.1 Global Fetal Calf Serum (FCS) Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Fetal Calf Serum (FCS) Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Fetal Calf Serum (FCS)
3.4 Market Concentration Rate
3.4.1 Top 3 Fetal Calf Serum (FCS) Manufacturer Market Share in 2021
3.4.2 Top 6 Fetal Calf Serum (FCS) Manufacturer Market Share in 2021
3.5 Global Fetal Calf Serum (FCS) Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Fetal Calf Serum (FCS) Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Fetal Calf Serum (FCS) Market Size by Region
4.1.1 Global Fetal Calf Serum (FCS) Sales in Volume by Region (2017-2028)
4.1.2 Global Fetal Calf Serum (FCS) Revenue by Region (2017-2028)
4.2 North America Fetal Calf Serum (FCS) Revenue (2017-2028)
4.3 Europe Fetal Calf Serum (FCS) Revenue (2017-2028)
4.4 Asia-Pacific Fetal Calf Serum (FCS) Revenue (2017-2028)
4.5 South America Fetal Calf Serum (FCS) Revenue (2017-2028)
4.6 Middle East and Africa Fetal Calf Serum (FCS) Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Fetal Calf Serum (FCS) Sales in Volume by Type (2017-2028)
5.2 Global Fetal Calf Serum (FCS) Revenue by Type (2017-2028)
5.3 Global Fetal Calf Serum (FCS) Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Fetal Calf Serum (FCS) Sales in Volume by Application (2017-2028)
6.2 Global Fetal Calf Serum (FCS) Revenue by Application (2017-2028)
6.3 Global Fetal Calf Serum (FCS) Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Fetal Calf Serum (FCS) Sales by Type (2017-2028)
7.2 North America Fetal Calf Serum (FCS) Sales by Application (2017-2028)
7.3 North America Fetal Calf Serum (FCS) Market Size by Country
7.3.1 North America Fetal Calf Serum (FCS) Sales in Volume by Country (2017-2028)
7.3.2 North America Fetal Calf Serum (FCS) Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Fetal Calf Serum (FCS) Sales by Type (2017-2028)
8.2 Europe Fetal Calf Serum (FCS) Sales by Application (2017-2028)
8.3 Europe Fetal Calf Serum (FCS) Market Size by Country
8.3.1 Europe Fetal Calf Serum (FCS) Sales in Volume by Country (2017-2028)
8.3.2 Europe Fetal Calf Serum (FCS) Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Fetal Calf Serum (FCS) Sales by Type (2017-2028)
9.2 Asia-Pacific Fetal Calf Serum (FCS) Sales by Application (2017-2028)
9.3 Asia-Pacific Fetal Calf Serum (FCS) Market Size by Region
9.3.1 Asia-Pacific Fetal Calf Serum (FCS) Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Fetal Calf Serum (FCS) Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Fetal Calf Serum (FCS) Sales by Type (2017-2028)
10.2 South America Fetal Calf Serum (FCS) Sales by Application (2017-2028)
10.3 South America Fetal Calf Serum (FCS) Market Size by Country
10.3.1 South America Fetal Calf Serum (FCS) Sales in Volume by Country (2017-2028)
10.3.2 South America Fetal Calf Serum (FCS) Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Fetal Calf Serum (FCS) Sales by Type (2017-2028)
11.2 Middle East & Africa Fetal Calf Serum (FCS) Sales by Application (2017-2028)
11.3 Middle East & Africa Fetal Calf Serum (FCS) Market Size by Country
11.3.1 Middle East & Africa Fetal Calf Serum (FCS) Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Fetal Calf Serum (FCS) Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Fetal Calf Serum (FCS) and Key Manufacturers
12.2 Manufacturing Costs Percentage of Fetal Calf Serum (FCS)
12.3 Fetal Calf Serum (FCS) Production Process
12.4 Fetal Calf Serum (FCS) Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Fetal Calf Serum (FCS) Typical Distributors
13.3 Fetal Calf Serum (FCS) Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Fetal Calf Serum (FCS) Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Fetal Calf Serum (FCS) Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Thermo Fisher Basic Information, Manufacturing Base and Competitors
Table 4. Thermo Fisher Major Business
Table 5. Thermo Fisher Fetal Calf Serum (FCS) Product and Services
Table 6. Thermo Fisher Fetal Calf Serum (FCS) Sales (L), Price (USD/L), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. GE Healthcare Basic Information, Manufacturing Base and Competitors
Table 8. GE Healthcare Major Business
Table 9. GE Healthcare Fetal Calf Serum (FCS) Product and Services
Table 10. GE Healthcare Fetal Calf Serum (FCS) Sales (L), Price (USD/L), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Sigma-Aldrich Basic Information, Manufacturing Base and Competitors
Table 12. Sigma-Aldrich Major Business
Table 13. Sigma-Aldrich Fetal Calf Serum (FCS) Product and Services
Table 14. Sigma-Aldrich Fetal Calf Serum (FCS) Sales (L), Price (USD/L), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Merck Basic Information, Manufacturing Base and Competitors
Table 16. Merck Major Business
Table 17. Merck Fetal Calf Serum (FCS) Product and Services
Table 18. Merck Fetal Calf Serum (FCS) Sales (L), Price (USD/L), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Moregate BioTech Basic Information, Manufacturing Base and Competitors
Table 20. Moregate BioTech Major Business
Table 21. Moregate BioTech Fetal Calf Serum (FCS) Product and Services
Table 22. Moregate BioTech Fetal Calf Serum (FCS) Sales (L), Price (USD/L), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Gemini Basic Information, Manufacturing Base and Competitors
Table 24. Gemini Major Business
Table 25. Gemini Fetal Calf Serum (FCS) Product and Services
Table 26. Gemini Fetal Calf Serum (FCS) Sales (L), Price (USD/L), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Atlanta Biologicals Basic Information, Manufacturing Base and Competitors
Table 28. Atlanta Biologicals Major Business
Table 29. Atlanta Biologicals Fetal Calf Serum (FCS) Product and Services
Table 30. Atlanta Biologicals Fetal Calf Serum (FCS) Sales (L), Price (USD/L), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Tissue Culture Biologicals Basic Information, Manufacturing Base and Competitors
Table 32. Tissue Culture Biologicals Major Business
Table 33. Tissue Culture Biologicals Fetal Calf Serum (FCS) Product and Services
Table 34. Tissue Culture Biologicals Fetal Calf Serum (FCS) Sales (L), Price (USD/L), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Bovogen Basic Information, Manufacturing Base and Competitors
Table 36. Bovogen Major Business
Table 37. Bovogen Fetal Calf Serum (FCS) Product and Services
Table 38. Bovogen Fetal Calf Serum (FCS) Sales (L), Price (USD/L), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Biowest Basic Information, Manufacturing Base and Competitors
Table 40. Biowest Major Business
Table 41. Biowest Fetal Calf Serum (FCS) Product and Services
Table 42. Biowest Fetal Calf Serum (FCS) Sales (L), Price (USD/L), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Internegocios Basic Information, Manufacturing Base and Competitors
Table 44. Internegocios Major Business
Table 45. Internegocios Fetal Calf Serum (FCS) Product and Services
Table 46. Internegocios Fetal Calf Serum (FCS) Sales (L), Price (USD/L), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. RMBIO Basic Information, Manufacturing Base and Competitors
Table 48. RMBIO Major Business
Table 49. RMBIO Fetal Calf Serum (FCS) Product and Services
Table 50. RMBIO Fetal Calf Serum (FCS) Sales (L), Price (USD/L), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Biological Industries Basic Information, Manufacturing Base and Competitors
Table 52. Biological Industries Major Business
Table 53. Biological Industries Fetal Calf Serum (FCS) Product and Services
Table 54. Biological Industries Fetal Calf Serum (FCS) Sales (L), Price (USD/L), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. PAN-Biotech Basic Information, Manufacturing Base and Competitors
Table 56. PAN-Biotech Major Business
Table 57. PAN-Biotech Fetal Calf Serum (FCS) Product and Services
Table 58. PAN-Biotech Fetal Calf Serum (FCS) Sales (L), Price (USD/L), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. VWR Basic Information, Manufacturing Base and Competitors
Table 60. VWR Major Business
Table 61. VWR Fetal Calf Serum (FCS) Product and Services
Table 62. VWR Fetal Calf Serum (FCS) Sales (L), Price (USD/L), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. Corning Basic Information, Manufacturing Base and Competitors
Table 64. Corning Major Business
Table 65. Corning Fetal Calf Serum (FCS) Product and Services
Table 66. Corning Fetal Calf Serum (FCS) Sales (L), Price (USD/L), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 67. Global Fetal Calf Serum (FCS) Sales by Manufacturer (2019, 2020, 2021, and 2022) & (L)
Table 68. Global Fetal Calf Serum (FCS) Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 69. Market Position of Manufacturers in Fetal Calf Serum (FCS), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 70. Global Fetal Calf Serum (FCS) Production Capacity by Company, (L): 2020 VS 2021
Table 71. Head Office and Fetal Calf Serum (FCS) Production Site of Key Manufacturer
Table 72. Fetal Calf Serum (FCS) New Entrant and Capacity Expansion Plans
Table 73. Fetal Calf Serum (FCS) Mergers & Acquisitions in the Past Five Years
Table 74. Global Fetal Calf Serum (FCS) Sales by Region (2017-2022) & (L)
Table 75. Global Fetal Calf Serum (FCS) Sales by Region (2023-2028) & (L)
Table 76. Global Fetal Calf Serum (FCS) Revenue by Region (2017-2022) & (USD Million)
Table 77. Global Fetal Calf Serum (FCS) Revenue by Region (2023-2028) & (USD Million)
Table 78. Global Fetal Calf Serum (FCS) Sales by Type (2017-2022) & (L)
Table 79. Global Fetal Calf Serum (FCS) Sales by Type (2023-2028) & (L)
Table 80. Global Fetal Calf Serum (FCS) Revenue by Type (2017-2022) & (USD Million)
Table 81. Global Fetal Calf Serum (FCS) Revenue by Type (2023-2028) & (USD Million)
Table 82. Global Fetal Calf Serum (FCS) Price by Type (2017-2022) & (USD/L)
Table 83. Global Fetal Calf Serum (FCS) Price by Type (2023-2028) & (USD/L)
Table 84. Global Fetal Calf Serum (FCS) Sales by Application (2017-2022) & (L)
Table 85. Global Fetal Calf Serum (FCS) Sales by Application (2023-2028) & (L)
Table 86. Global Fetal Calf Serum (FCS) Revenue by Application (2017-2022) & (USD Million)
Table 87. Global Fetal Calf Serum (FCS) Revenue by Application (2023-2028) & (USD Million)
Table 88. Global Fetal Calf Serum (FCS) Price by Application (2017-2022) & (USD/L)
Table 89. Global Fetal Calf Serum (FCS) Price by Application (2023-2028) & (USD/L)
Table 90. North America Fetal Calf Serum (FCS) Sales by Country (2017-2022) & (L)
Table 91. North America Fetal Calf Serum (FCS) Sales by Country (2023-2028) & (L)
Table 92. North America Fetal Calf Serum (FCS) Revenue by Country (2017-2022) & (USD Million)
Table 93. North America Fetal Calf Serum (FCS) Revenue by Country (2023-2028) & (USD Million)
Table 94. North America Fetal Calf Serum (FCS) Sales by Type (2017-2022) & (L)
Table 95. North America Fetal Calf Serum (FCS) Sales by Type (2023-2028) & (L)
Table 96. North America Fetal Calf Serum (FCS) Sales by Application (2017-2022) & (L)
Table 97. North America Fetal Calf Serum (FCS) Sales by Application (2023-2028) & (L)
Table 98. Europe Fetal Calf Serum (FCS) Sales by Country (2017-2022) & (L)
Table 99. Europe Fetal Calf Serum (FCS) Sales by Country (2023-2028) & (L)
Table 100. Europe Fetal Calf Serum (FCS) Revenue by Country (2017-2022) & (USD Million)
Table 101. Europe Fetal Calf Serum (FCS) Revenue by Country (2023-2028) & (USD Million)
Table 102. Europe Fetal Calf Serum (FCS) Sales by Type (2017-2022) & (L)
Table 103. Europe Fetal Calf Serum (FCS) Sales by Type (2023-2028) & (L)
Table 104. Europe Fetal Calf Serum (FCS) Sales by Application (2017-2022) & (L)
Table 105. Europe Fetal Calf Serum (FCS) Sales by Application (2023-2028) & (L)
Table 106. Asia-Pacific Fetal Calf Serum (FCS) Sales by Region (2017-2022) & (L)
Table 107. Asia-Pacific Fetal Calf Serum (FCS) Sales by Region (2023-2028) & (L)
Table 108. Asia-Pacific Fetal Calf Serum (FCS) Revenue by Region (2017-2022) & (USD Million)
Table 109. Asia-Pacific Fetal Calf Serum (FCS) Revenue by Region (2023-2028) & (USD Million)
Table 110. Asia-Pacific Fetal Calf Serum (FCS) Sales by Type (2017-2022) & (L)
Table 111. Asia-Pacific Fetal Calf Serum (FCS) Sales by Type (2023-2028) & (L)
Table 112. Asia-Pacific Fetal Calf Serum (FCS) Sales by Application (2017-2022) & (L)
Table 113. Asia-Pacific Fetal Calf Serum (FCS) Sales by Application (2023-2028) & (L)
Table 114. South America Fetal Calf Serum (FCS) Sales by Country (2017-2022) & (L)
Table 115. South America Fetal Calf Serum (FCS) Sales by Country (2023-2028) & (L)
Table 116. South America Fetal Calf Serum (FCS) Revenue by Country (2017-2022) & (USD Million)
Table 117. South America Fetal Calf Serum (FCS) Revenue by Country (2023-2028) & (USD Million)
Table 118. South America Fetal Calf Serum (FCS) Sales by Type (2017-2022) & (L)
Table 119. South America Fetal Calf Serum (FCS) Sales by Type (2023-2028) & (L)
Table 120. South America Fetal Calf Serum (FCS) Sales by Application (2017-2022) & (L)
Table 121. South America Fetal Calf Serum (FCS) Sales by Application (2023-2028) & (L)
Table 122. Middle East & Africa Fetal Calf Serum (FCS) Sales by Region (2017-2022) & (L)
Table 123. Middle East & Africa Fetal Calf Serum (FCS) Sales by Region (2023-2028) & (L)
Table 124. Middle East & Africa Fetal Calf Serum (FCS) Revenue by Region (2017-2022) & (USD Million)
Table 125. Middle East & Africa Fetal Calf Serum (FCS) Revenue by Region (2023-2028) & (USD Million)
Table 126. Middle East & Africa Fetal Calf Serum (FCS) Sales by Type (2017-2022) & (L)
Table 127. Middle East & Africa Fetal Calf Serum (FCS) Sales by Type (2023-2028) & (L)
Table 128. Middle East & Africa Fetal Calf Serum (FCS) Sales by Application (2017-2022) & (L)
Table 129. Middle East & Africa Fetal Calf Serum (FCS) Sales by Application (2023-2028) & (L)
Table 130. Fetal Calf Serum (FCS) Raw Material
Table 131. Key Manufacturers of Fetal Calf Serum (FCS) Raw Materials
Table 132. Direct Channel Pros & Cons
Table 133. Indirect Channel Pros & Cons
Table 134. Fetal Calf Serum (FCS) Typical Distributors
Table 135. Fetal Calf Serum (FCS) Typical Customers
List of Figures
Figure 1. Fetal Calf Serum (FCS) Picture
Figure 2. Global Fetal Calf Serum (FCS) Revenue Market Share by Type in 2021
Figure 3. North America-sourced
Figure 4. South America-sourced
Figure 5. Australia-sourced
Figure 6. Others
Figure 7. Global Fetal Calf Serum (FCS) Revenue Market Share by Application in 2021
Figure 8. Research & Development
Figure 9. Commercial Production
Figure 10. Global Fetal Calf Serum (FCS) Revenue, (USD Million) & (L): 2017 & 2021 & 2028
Figure 11. Global Fetal Calf Serum (FCS) Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global Fetal Calf Serum (FCS) Sales (2017-2028) & (L)
Figure 13. Global Fetal Calf Serum (FCS) Price (2017-2028) & (USD/L)
Figure 14. Global Fetal Calf Serum (FCS) Production Capacity (2017-2028) & (L)
Figure 15. Global Fetal Calf Serum (FCS) Production Capacity by Geographic Region: 2022 VS 2028
Figure 16. Fetal Calf Serum (FCS) Market Drivers
Figure 17. Fetal Calf Serum (FCS) Market Restraints
Figure 18. Fetal Calf Serum (FCS) Market Trends
Figure 19. Global Fetal Calf Serum (FCS) Sales Market Share by Manufacturer in 2021
Figure 20. Global Fetal Calf Serum (FCS) Revenue Market Share by Manufacturer in 2021
Figure 21. Fetal Calf Serum (FCS) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 22. Top 3 Fetal Calf Serum (FCS) Manufacturer (Revenue) Market Share in 2021
Figure 23. Top 6 Fetal Calf Serum (FCS) Manufacturer (Revenue) Market Share in 2021
Figure 24. Global Fetal Calf Serum (FCS) Sales Market Share by Region (2017-2028)
Figure 25. Global Fetal Calf Serum (FCS) Revenue Market Share by Region (2017-2028)
Figure 26. North America Fetal Calf Serum (FCS) Revenue (2017-2028) & (USD Million)
Figure 27. Europe Fetal Calf Serum (FCS) Revenue (2017-2028) & (USD Million)
Figure 28. Asia-Pacific Fetal Calf Serum (FCS) Revenue (2017-2028) & (USD Million)
Figure 29. South America Fetal Calf Serum (FCS) Revenue (2017-2028) & (USD Million)
Figure 30. Middle East & Africa Fetal Calf Serum (FCS) Revenue (2017-2028) & (USD Million)
Figure 31. Global Fetal Calf Serum (FCS) Sales Market Share by Type (2017-2028)
Figure 32. Global Fetal Calf Serum (FCS) Revenue Market Share by Type (2017-2028)
Figure 33. Global Fetal Calf Serum (FCS) Price by Type (2017-2028) & (USD/L)
Figure 34. Global Fetal Calf Serum (FCS) Sales Market Share by Application (2017-2028)
Figure 35. Global Fetal Calf Serum (FCS) Revenue Market Share by Application (2017-2028)
Figure 36. Global Fetal Calf Serum (FCS) Price by Application (2017-2028) & (USD/L)
Figure 37. North America Fetal Calf Serum (FCS) Sales Market Share by Type (2017-2028)
Figure 38. North America Fetal Calf Serum (FCS) Sales Market Share by Application (2017-2028)
Figure 39. North America Fetal Calf Serum (FCS) Sales Market Share by Country (2017-2028)
Figure 40. North America Fetal Calf Serum (FCS) Revenue Market Share by Country (2017-2028)
Figure 41. United States Fetal Calf Serum (FCS) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Canada Fetal Calf Serum (FCS) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Mexico Fetal Calf Serum (FCS) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Europe Fetal Calf Serum (FCS) Sales Market Share by Type (2017-2028)
Figure 45. Europe Fetal Calf Serum (FCS) Sales Market Share by Application (2017-2028)
Figure 46. Europe Fetal Calf Serum (FCS) Sales Market Share by Country (2017-2028)
Figure 47. Europe Fetal Calf Serum (FCS) Revenue Market Share by Country (2017-2028)
Figure 48. Germany Fetal Calf Serum (FCS) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. France Fetal Calf Serum (FCS) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. United Kingdom Fetal Calf Serum (FCS) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Russia Fetal Calf Serum (FCS) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Italy Fetal Calf Serum (FCS) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Asia-Pacific Fetal Calf Serum (FCS) Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Fetal Calf Serum (FCS) Sales Market Share by Application (2017-2028)
Figure 55. Asia-Pacific Fetal Calf Serum (FCS) Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Fetal Calf Serum (FCS) Revenue Market Share by Region (2017-2028)
Figure 57. China Fetal Calf Serum (FCS) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Japan Fetal Calf Serum (FCS) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Korea Fetal Calf Serum (FCS) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. India Fetal Calf Serum (FCS) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Southeast Asia Fetal Calf Serum (FCS) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Australia Fetal Calf Serum (FCS) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South America Fetal Calf Serum (FCS) Sales Market Share by Type (2017-2028)
Figure 64. South America Fetal Calf Serum (FCS) Sales Market Share by Application (2017-2028)
Figure 65. South America Fetal Calf Serum (FCS) Sales Market Share by Country (2017-2028)
Figure 66. South America Fetal Calf Serum (FCS) Revenue Market Share by Country (2017-2028)
Figure 67. Brazil Fetal Calf Serum (FCS) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina Fetal Calf Serum (FCS) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East & Africa Fetal Calf Serum (FCS) Sales Market Share by Type (2017-2028)
Figure 70. Middle East & Africa Fetal Calf Serum (FCS) Sales Market Share by Application (2017-2028)
Figure 71. Middle East & Africa Fetal Calf Serum (FCS) Sales Market Share by Region (2017-2028)
Figure 72. Middle East & Africa Fetal Calf Serum (FCS) Revenue Market Share by Region (2017-2028)
Figure 73. Turkey Fetal Calf Serum (FCS) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Egypt Fetal Calf Serum (FCS) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia Fetal Calf Serum (FCS) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. South Africa Fetal Calf Serum (FCS) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Manufacturing Cost Structure Analysis of Fetal Calf Serum (FCS) in 2021
Figure 78. Manufacturing Process Analysis of Fetal Calf Serum (FCS)
Figure 79. Fetal Calf Serum (FCS) Industrial Chain
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/



※注目の調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(GIR22NO19323 )"世界の牛胎児血清(FCS)市場2022年:市場規模予測(~2028年)" (英文:Global Fetal Calf Serum (FCS) Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。